The authors reply

Affiliations

¹ Division of Critical Care, McMaster University, Hamilton, ON, Canada; Division of Gastroenterology, McMaster University, Hamilton, ON, Canada; Division of Critical Care, McMaster University, Hamilton, ON, Canada.

Comment

Waleed Alhazzani et al. Crit Care Med. 2013 Nov.

. 2013 Nov;41(11):e397-8.

doi: 10.1097/CCM.0b013e3182a42e5d.

¹ Division of Critical Care, McMaster University, Hamilton, ON, Canada; Division of Gastroenterology, McMaster University, Hamilton, ON, Canada; Division of Critical Care, McMaster University, Hamilton, ON, Canada.

No abstract available

Comment on

The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials.
Alhazzani W, Jacobi J, Sindi A, Hartog C, Reinhart K, Kokkoris S, Gerlach H, Andrews P, Drabek T, Manzanares W, Cook DJ, Jaeschke RZ. Alhazzani W, et al. Crit Care Med. 2013 Jun;41(6):1555-64. doi: 10.1097/CCM.0b013e31828a24c6. Crit Care Med. 2013. PMID: 23587641
Selenium for sepsis: what have we learned so far?
Huang TS, Shyu YC, Yuan SS, Chen PJ. Huang TS, et al. Crit Care Med. 2013 Nov;41(11):e396. doi: 10.1097/CCM.0b013e3182a12289. Crit Care Med. 2013. PMID: 24162703 No abstract available.
Proton pump inhibitors in patients with end-stage liver disease.
Al-Khafaji A, Garavaglia JM. Al-Khafaji A, et al. Crit Care Med. 2013 Nov;41(11):e396-7. doi: 10.1097/CCM.0b013e318298251b. Crit Care Med. 2013. PMID: 24162704 No abstract available.